Edition:
United States

PharMerica Corp (PMC.N)

PMC.N on New York Stock Exchange

24.85USD
5 Dec 2016
Change (% chg)

$0.70 (+2.90%)
Prev Close
$24.15
Open
$24.15
Day's High
$24.95
Day's Low
$24.15
Volume
85,672
Avg. Vol
81,920
52-wk High
$35.42
52-wk Low
$19.20

PMC.N

Chart for PMC.N

About

PharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals, provides specialty infusion services to patients outside a hospital setting and offers the national oncology pharmacy in the United States. It has three segments:... (more)

Overall

Beta: 0.97
Market Cap(Mil.): $746.46
Shares Outstanding(Mil.): 30.78
Dividend: --
Yield (%): --

Financials

  PMC.N Industry Sector
P/E (TTM): 21.90 19.45 39.00
EPS (TTM): 1.11 -- --
ROI: 3.57 11.87 59.38
ROE: 6.60 13.66 67.12

PharMerica escapes case claiming kickbacks to nursing homes

By Brendan Pierson A federal judge has dismissed a whistleblower lawsuit accusing pharmacy services giant PharMerica Corp of paying kickbacks to nursing homes in exchange for prescription drug referrals, finding the whistleblower's complaint rested entirely on public documents.

Nov 29 2016

BRIEF-PharMerica reports third quarter 2016 results

* Sees FY 2016 revenue in range of $2.051 billion to $2.091 billion

Nov 09 2016

Specialty pharmacy PharMerica explores possible sale -sources

Aug 24 PharMerica Corp, a U.S. pharmacy manager for long-term care facilities, is exploring strategic alternatives, including a potential sale, according to people familiar with the matter.

Aug 24 2016

Appeals court tosses age bias lawsuit against PharMerica

A terminated employee cannot sue a pharmacy service provider for age discrimination based on its "sloppy management or arbitrary decision making," a federal appeals court ruled on Friday.

Aug 22 2016

BRIEF-Pharmerica Corp announces planned retirement of CFO David Froesel jr.

* Pharmerica Corporation announces planned retirement of chief financial officer david w. Froesel, jr.

Aug 09 2016

BRIEF-Pharmerica Q2 adjusted EPS $0.47

* Q2 revenue $519.6 million versus I/B/E/S view $508.3 million

Aug 09 2016

Competitors

  Price Chg
CVS Health Corp (CVS.N) $77.99 +0.37
AmerisourceBergen Corp. (ABC.N) $79.54 +0.74
Celesio AG (CLSGn.DE) €25.25 --

Earnings vs. Estimates